Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Warns Chinese Exporters Could Be Banned For Poor Drug Products

This article was originally published in PharmAsia News

Executive Summary

Chinese companies that export products to the United States could have their drug products barred if they fail to meet U.S. standards. Michael Leavitt, secretary of Health and Human Services, acknowledged during a visit to Beijing his country could not inspect everything imported into the United States, so it must rely on market forces to punish companies and countries that fail to meet product-quality certification standards. In his talks with officials, Leavitt seeks to close a loophole in Chinese regulations that allows ingredients for drugs to be produced without being inspected. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts